SCHEMBL26547883

SCHEMBL26547883

COCCOc1ccnc(NC(C)C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.43
HRH4 Q9H3N8 4/20 0.41
KRAS P01116 1/20 0.37
SOS1 Q07889 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
KMT2A Q03164 1/20 0.37
PKM P14618 1/20 0.36
LMNA P02545 2/20 0.36
CCR4 P51679 1/20 0.36
ABL1 P00519 1/20 0.36
LCK P06239 1/20 0.36
CSF1R P07333 1/20 0.36
PDGFRB P09619 1/20 0.36
MAP2K2 P36507 1/20 0.36
CDK7 P50613 1/20 0.36
ACACB O00763 1/20 0.36
FLT3 P36888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26547881 0.84 MAPK8 (0.47) MAPK8HRH4SMN1; SMN2MEN1CYP1A2
SCHEMBL12411107 0.82 HTR7 (0.47) MAPK8HRH4LMNACCR4HTR7
SCHEMBL12411165 0.82 MAPK8 (0.49) MAPK8HRH4MEN1CYP1A2KMT2A
SCHEMBL26550296 0.79 ALDH1A1 (0.40) SMN1; SMN2TSHRMEN1CYP1A2KMT2A
SCHEMBL2017242 0.73 TSHR (0.39) SMN1; SMN2TSHRACACB
SCHEMBL8000442 0.72 CHRNB1 (0.49)
SCHEMBL12411129 0.72 MAPK8 (0.41) MAPK8HRH4MEN1CYP1A2KMT2A
SCHEMBL31201109 0.71 NUDT1 (0.59) HRH4TSHR
SCHEMBL12411162 0.69 MAPK8 (0.47) MAPK8HRH4SMN1; SMN2MEN1CYP1A2
SCHEMBL2844731 0.69 ABL1 (0.52) MAPK8HRH4MEN1KMT2AABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed